Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
How to manage: Inject in the evening so you sleep through peak nausea Eat smaller, lighter meals avoid fried, fatty, or spicy food Stay hydrated with at least 2.5 L of water daily Rotate injection sites (abdomen, thigh, upper arm) Week 2 Symptoms Stabilise Dose: still 0.25 mg Most patients report nausea has stabilised or begun to ease
Start your intake What Ivim Health is Ivim Health operates as telehealth paired with a compounded-pharmacy pathway
Specifically, retatrutide is intended to activate the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor a combination that distinguishes it from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP/GLP-1 receptor agonist)
The research is still early, but here is what we know: GIP and thyroid hormone release: GIP has been shown to stimulate the release of calcitonin from thyroid C-cells in animal models
